ABVC
ABVC BIOPHARMA, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.16
+0.87%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 0.88x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 77.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.01x
- Price / sales
- -38.85x
- Price / cash flow
- -11.49x
Enterprise value
- Enterprise value
- $34.6M
- EV / sales
- -43.43x
- EV / EBITDA
- -4.42x
- EV / EBIT
- -4.73x
- Market cap
- $30.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026